Corrigendum to A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma [AnnOncol 2013, 24, 3076-3081] doi: 10.1093/annonc/mdt414

A. M. Evens, K. R. Carson, J. Kolesar, C. Nabhan, I. Helenowski, N. Islam, B. Jovanovic, P. M. Barr, P. F. Caimi, S. A. Gregory, L. I. Gordon

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Article numbermdu179
Pages (from-to)1449
Number of pages1
JournalAnnals of Oncology
Issue number7
StatePublished - Jul 2014

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this